To investigate the role of astrocytes in NMDAR-dependent LTP, we focused on Schaffer collateral (SC) - CA1 pyramidal cell synapses, a classical subject of LTP studies. We patched passive *stratum radiatum* astrocytes ([Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}) and monitored SC-mediated field excitatory postsynaptic potentials (fEPSPs) in their immediate vicinity ([Fig. 1a-b](#F1){ref-type="fig"}, [Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}). A standard high-frequency stimulation (HFS) protocol induced LTP which was indistinguishable from that induced without patching an astrocyte ([Fig. 1c](#F1){ref-type="fig"}; Methods). Because the intracellular solution routinely contained the high-affinity Ca^2+^ indicator Oregon Green BAPTA-1 (OGB-1, 0.2 mM), these observations were in correspondence with studies documenting robust LTP near an astrocyte loaded with 10 mM ethylene glycol tetraacetic acid (EGTA)[@R14]-[@R16]. However, exogenous Ca^2+^ buffers, while suppressing rapid Ca^2+^ transients, are unlikely to affect equilibrated (resting) free Ca^2+^ controlled by active homeostatic mechanisms. To constrain free astrocytic Ca^2+^ more efficiently, we "clamped" its concentration at 50-80 nM, by adding 0.45 mM EGTA and 0.14 mM Ca^2+^ to the intracellular solution (Methods)[@R19]. Indeed, Ca^2+^ clamp abolished HFS-induced Ca^2+^ elevations which could be detected in astrocytes containing OGB-1 and EGTA only ([Supplementary Fig. 2](#SD1){ref-type="supplementary-material"}). Furthermore, biophysical simulations suggested that Ca^2+^ clamp could restrict Ca^2+^ nanodomains more efficiently than buffers alone ([Supplementary Fig. 3](#SD1){ref-type="supplementary-material"}).

Strikingly, clamping intra-astrocyte Ca^2+^ completely suppressed LTP at nearby synapses, and adding 10 μM D-serine fully rescued it ([Fig. 1d](#F1){ref-type="fig"}). D-serine alone had no effect on LTP in control conditions (consistent with previous reports[@R20]) whereas the NMDAR antagonist (2*R*)-amino-5-phosphonovaleric acid (APV) completely blocked it ([Fig. 1e-f](#F1){ref-type="fig"}). These observations imply that Ca^2+^-dependent astrocyte activity could indeed control supply of an NMDAR co-agonist essential for LTP induction[@R4],[@R5],[@R18],[@R21]. To understand the underlying mechanisms, we recorded SC-evoked NMDAR fEPSPs near the patched astrocyte ([Fig. 1a-b](#F1){ref-type="fig"}; Methods) while switching from cell-attached to whole-cell configuration ([Fig. 2a](#F2){ref-type="fig"}). The control pipette solution (Methods) had little influence on NMDAR responses (change 9 ± 6% relative to baseline, n = 6; [Fig. 2a-b](#F2){ref-type="fig"}) whereas Ca^2+^ clamp reduced them by 22 ± 4% (n = 13, p \< 0.0001). This reduction was reversed by the subsequent application of D-serine (10 ± 9% relative to baseline, n = 7, p = 0.0012; [Fig. 2a-b](#F2){ref-type="fig"}; [Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}), and having D-serine from the start blocked the inhibitory effect of Ca^2+^ clamp (15 ± 12%, n = 7; [Fig. 2a-b](#F2){ref-type="fig"}). Ca^2+^-dependent astrocyte signalling could therefore regulate the occupancy of the NMDAR co-agonist site.

In resting conditions, 10 μM D-serine increased NMDAR-mediated excitatory postsynaptic currents (EPSCs) in CA1 pyramidal cells (by 29 ± 10%; n = 5, p = 0.039; [Fig. 2c](#F2){ref-type="fig"}) as well as local NMDAR fEPSPs (by 25.3 ± 3.0%, n = 8, p \< 0.001; [Supplementary Fig. 5](#SD1){ref-type="supplementary-material"}) indicating that the NMDAR co-agonist sites were not saturated in baseline conditions, consistent with recent observations in hippocampal slices[@R22] and in vivo[@R23]. Interestingly, LTP induction had no long-term effect on the NMDAR co-agonist site occupancy: D-serine applied 25 min post-induction equally increased NMDAR EPSCs (by 23 ± 8%, n = 6, p = 0.034, [Fig. 2c](#F2){ref-type="fig"}) and fEPSPs (by 24.7 ± 9.1%; n = 6, p = 0.042, [Supplementary Fig. 5](#SD1){ref-type="supplementary-material"}), which was indistinguishable from the pre-induction effects. In contrast, even mild repetitive stimulation of SCs (10 stimuli at 50 Hz) was sufficient to boost the co-agonist site occupancy transiently: short-term potentiation of the NMDAR-mediated EPSC component 20 s post-train was reduced by 20 ± 7% (n = 6, p = 0.043) when the co-agonist site was saturated by 0.1 mM glycine, before returning to the baseline level two minutes later ([Fig. 2d](#F2){ref-type="fig"}). This was not due to changes in cell excitability or release probability because similar potentiation of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) responses showed no glycine sensitivity ([Fig. 2d](#F2){ref-type="fig"}; [Supplementary Fig. 6](#SD1){ref-type="supplementary-material"}). Furthermore, the glial metabolic poison fluoroacetate (FAC, 5 mM) made the NMDAR EPSC potentiation also insensitive to glycine, thus implicating glia ([Fig. 2d](#F2){ref-type="fig"}; [Supplementary Fig. 6](#SD1){ref-type="supplementary-material"}). In striking correspondence with these observations, HFS induced transient Ca^2+^ elevations in 54% of astrocytes (consistent with earlier reports[@R24]) but no long-term changes in spontaneous Ca^2+^ activity ([Supplementary Fig. 7](#SD1){ref-type="supplementary-material"}).

If astrocytes enable LTP induction by increasing activation of the NMDAR co-agonist site then reducing the site availability should prevent LTP[@R25]. To replicate the \~25% decrease of NMDAR responses under astrocytic Ca^2+^ clamp ([Fig. 2a-b](#F2){ref-type="fig"}), we used the selective NMDAR glycine site blocker 5,7-dichlorokynurenic acid (DCKA) at 750 nM ([Fig. 3a](#F3){ref-type="fig"} and [Supplementary Fig. 8](#SD1){ref-type="supplementary-material"}). Strikingly, 750 nM DCKA abolished LTP just as did 50 μM APV ([Fig. 3a](#F3){ref-type="fig"}). Consistent both with these observations and with the Ca^2+^ clamp effects, FAC also reduced NMDAR fEPSPs by 23 ± 4% (n = 16, p = 0.00017; [Supplementary Fig. 9a-b](#SD1){ref-type="supplementary-material"}) and blocked LTP in a D-serine-sensitive manner ([Fig. 3b-c](#F3){ref-type="fig"}). Although the mechanisms and specificity of FAC actions are incompletely understood, we confirmed that the effect of FAC on NMDAR fEPSPs (i) paralleled that on LTP ([Supplementary Fig. 9c-d](#SD1){ref-type="supplementary-material"}), (ii) was absent in glycine, and (iii) did not involve changes in release probability or axonal excitability ([Supplementary Fig. 10](#SD1){ref-type="supplementary-material"}).

Such experiments however provide no direct evidence for D-serine release from astroglia: an alternative scenario is that an NMDAR co-agonist is released from elsewhere, e.g. neurons[@R12],[@R13], in response to an unknown astrocytic signal. To investigate this, we blocked D-serine synthesis inside an astrocyte using the relatively specific serine racemase inhibitor L-erythro-3-hydroxyaspartate (HOAsp)[@R26] loaded at 400 μM (to suppress competition from L-serine), but found no effect on local LTP ([Fig. 3d](#F3){ref-type="fig"}). However, HOAsp does not influence D-serine itself and therefore cannot prevent release of the stored agonist. We therefore attempted to deplete the putative astrocytic D-serine pool by applying HFS in the presence of APV. When APV was washed out and HFS applied again, LTP induction was indeed suppressed whereas the same protocol with no HOAsp loaded yielded robust potentiation ([Fig. 3e-f](#F3){ref-type="fig"}). This result demonstrates causality between astrocytic synthesis of D-serine and local LTP.

How far do individual CA1 astrocytes extent their influence on LTP? Although astrocytes occupy separate domains[@R27], they can communicate through gap junctions[@R28] which are left intact in the present study. To determine whether these cells could act independently, we monitored LTP simultaneously in two neighbouring areas associated with two astrocytes. Firstly, we confirmed that field potentials recorded through an astrocytic patch-pipette reliably represent local fEPSPs, with no bias from glutamate transporter or potassium currents[@R14] ([Supplementary Fig. 11](#SD1){ref-type="supplementary-material"}). We next patched two neighbouring astrocytes and monitored SC-evoked "astrocytic" fEPSPs (a-fEPSPs) representing the two respective areas ([Fig. 4a-c](#F4){ref-type="fig"}). Clamping Ca^2+^ in one astrocyte suppressed LTP at nearby synapses but not at synapses near the neighbouring, control cell ([Fig. 4d-e](#F4){ref-type="fig"}​,​ [Supplementary Fig. 12](#SD1){ref-type="supplementary-material"}). A qualitatively identical result was obtained when putative vesicular exocytosis of D-serine[@R21],[@R29] in the test astrocyte was suppressed by the light-chain tetanus toxin (LC-TT; [Fig. 4f-g](#F4){ref-type="fig"}, [Supplementary Fig. 12](#SD1){ref-type="supplementary-material"}). In complementary experiments, we varied the distance between the extracellular recording pipette and the patched astrocyte. In Ca^2+^ clamp conditions, LTP partly recovered at 70-100 μm from the patched soma reaching its full strength at \>200 μm, consistent with the profile of Alexa escaping to neighbouring cells ([Fig. 4h](#F4){ref-type="fig"}, [Supplementary Fig. 13](#SD1){ref-type="supplementary-material"}). With a LC-TT-loaded astrocyte, LTP recovery occurred at markedly shorter distances ([Fig. 4h](#F4){ref-type="fig"}), consistent with the toxin\'s inability to cross gap junctions.

Our findings demonstrate that induction of NMDAR-dependent LTP at excitatory hippocampal synapses depends on the availability of NMDARs provided by Ca^2+^-dependent release of D-serine from a local astrocyte. Repetitive synaptic activity transiently enhances D-serine supply by glia, paralleled by a short-term elevation in astrocytic Ca^2+^. Neighbouring astrocytes may have distinct effects on local synapses, but also extend their influence beyond their morphological boundaries. This could potentially give rise to a Hebbian mechanism regulating hetero-synaptic NMDAR-dependent plasticity across a neuropil domain affected by an activated astrocyte. The importance of D-serine for LTP does not exclude the potential role of astrocytic glutamate release[@R6],[@R8], and the precise mechanisms acting on the microscopic scale require further investigation. Individual astrocytes occupy \~9·10^4^ μm^3^ of CA1 neuropil (while overlapping by only 3-10%)[@R27], and the numeric synaptic density in this area is \~2 μm^−3^ (ref.[@R30]) thus suggesting that a single astrocyte could affect synaptic plasticity on hundreds of principal cells.

METHODS SUMMARY {#S1}
===============

Whole-cell recordings from passive astrocytes (n = 146) were made in *stratum radiatum*, area CA1 in acute transverse hippocampal slices prepared from adult rats. Cells (30-100 μm deep inside the slice) were loaded with a bright morphological tracer Alexa Fluor 594 and the high-affinity Ca^2+^ indicator Oregon Green BAPTA (OGB-1) and imaged in two-photon excitation mode (λ^2p^~x~ = 800 nm). Field EPSPs were recorded using either an extracellular recording electrode placed in the immediate vicinity of the visualised astrocyte dendritic arbour or through the astrocytic patch pipette, as described. Whole-cell EPSCs were recorded from CA1 pyramidal cells. Electric stimuli were applied to Schaffer collateral fibres. LTP was induced by a standard high-frequency stimulation protocol (three 100-pulse trains at 100 Hz, 60 or 20 seconds apart). Inside the recorded astrocyte, conditions of Ca^2+^ homeostasis were altered using intracellular solutions containing EGTA, Oregon Green BAPTA-1, and CaCl~2~; the exocytosis machinery was suppressed using light-chain tetanus toxin; synthesis of D-serine was inhibited with serine racemase inhibitor L-erythro-3-hydroxyaspartate (HOAsp).

METHODS {#S2}
=======

Preparation {#S3}
-----------

350 μm thick acute hippocampal slices were obtained from four to eight week-old male Sprague-Dawley or Wistar rats, in full compliance with national guidelines on animal experimentation. Slices were prepared in an ice-cold slicing solution containing (in mM): NaCl 75, sucrose 80, KCl 2.5, MgCl~2~ 7, NaH~2~PO~4~ 1.25, CaCl~2~0.5, and glucose 6 (osmolarity 300-310 mOsm), stored in the slicing solution at 34°C for 15 minutes before being transferred to an interface chamber for storage in an extracellular solution containing (in mM) NaCl 119, KCl 2.5, MgSO~4~ 1.3, NaH~2~PO~4~ 1, NaHCO~3~ 26, CaCl~2~ 2, and glucose 10 (osmolarity adjusted to 295-305 using glucose). All solutions were continuously bubbled with 95% O~2~/ 5% CO~2~. Slices were allowed to rest for at least 60 minutes before recordings started. For recordings, slices were transferred to the submersion-type recording chamber and superperfused, at 23-26 °C, with artificial cerebrospinal fluid (ACSF) saturated with 95%O~2~/5%CO~2~ containing (in mM): 125 NaCl, 2.5 KCl, 1.25 NaH~2~PO~4~, 26 NaHCO~3~ and 12 glucose (pH 7.4; osmolarity 295-305) in the presence of 1.3 mM Mg^2+^ and either 2.0 or 2.5 mM Ca^2+^ (where necessary, 50 μM picrotoxin was added to block GABA~A~ receptors and a cut between CA3 and CA1 was made to suppress epileptiform activity).

Electrophysiology {#S4}
-----------------

Whole-cell recordings in astrocytes were obtained using standard patch pipettes (3-4 MΩ) filled with a "control" intracellular solution containing (in mM) KCH~3~O~3~S 135, HEPES 10, Na~2~-Phosphocreatine 10, MgCl~2~ 4, Na~2~-ATP 4, Na-GTP 0.4 (pH adjusted to 7.2 using KOH, osmolarity 290-295). Cell-impermeable dyes Oregon Green 488 BAPTA-1 (200 μM, Invitrogen) and Alexa Fluor 594 hydrazide (40 μM, Invitrogen) were routinely added to the intracellular solution, unless indicated otherwise. Passive (protoplasmic) astrocytes were identified, in accordance with established criteria[@R14],[@R31],[@R32], by their small soma size (\~ 10 μm; visualised in the Alexa emission channel), low resting potential (mean ± s.e.m.: −86.8 ± 1.2 mV, n = 146, no correction for the liquid-junction potential) and low input resistance (8.4 ± 0.6 MΩ, n = 146); we confirmed that they had passive (ohmic) properties and characteristic morphology of the arbour ([Fig. 1](#F1){ref-type="fig"} and [Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}). Cells that showed atypical morphologies (3 out of 186) were discarded. Astrocytes were either held in voltage clamp mode at their resting membrane potential or in current clamp. In some experiments, the recombinant tetanus toxin light chain (1 μM, LC-TT, Quadratech Diagnostics Ltd., UK) was included in the intracellular solution to disrupt vesicular release[@R33]. Where specified, 0.45 mM EGTA and 0.14 mM CaCl~2~ were added to the control intracellular solution to clamp intracellular free Ca^2+^ at a steady-state level of 50-80 nM (calculation by WebMaxChelator, Stanford). When required, the most effective to date specific serine racemase inhibitor L-erythro-3-hydroxyaspartate (HOAsp, Wako Chemicals; K~I~ = 49 μM)[@R26] was added to the intracellular solution.

Where indicated, the extracellular recording pipette was placed within the arbour or in the immediate vicinity of the patched astrocyte visualised in the Alexa channel, \<90 μm from the soma ([Fig. 1](#F1){ref-type="fig"}). Synaptic responses were evoked by orthodromic stimulation (100 μs, 40-120 μA) of Schaffer collaterals using either a bipolar or coaxial stimulation electrode placed in the stratum radiatum \>200 μm away from the recording electrodes. Field EPSPs (fEPSPs) were recorded using a standard patch pipette filled with the extracellular solution. Predominantly AMPAR-mediated fEPSPs (with no NMDAR blockers added) are denoted AMPAR fEPSPs throughout the text; where required, NMDAR fEPSPs were isolated using 10 μM NBQX and 0.2 mM Mg^2+^ in the bath medium (except for post-LTP recordings performed in 1.3 mM Mg^2+^, to maintain unchanged cell excitability).

The paired-pulse interval was 100 to 200 ms and the paired-pulse ratio was defined as the slope2/slope1 ratio. In some experiments, excitatory synaptic responses were monitored as field potentials recorded through one or two astrocyte patch-pipette in current clamp mode (a-fEPSP; [Supplementary Fig. 11](#SD1){ref-type="supplementary-material"}). The stimulus intensity was normally set at \~70% of that triggering population spikes, stimuli were applied every 30 seconds for at least 15 minutes before the LTP was induced using three trains of high-frequency stimulation (HFS, 100 pulses at 100 Hz), either 60 or 20 seconds apart. The slope of fEPSPs was monitored for subsequent 30-50 minutes.

Whole-cell recordings in CA1 pyramidal neurons were carried out using an intracellular solution containing (in mM) K-gluconate 130, KCl 5, HEPES, 10, Na~2~-Phosphocreatine 10, MgCl~2~ 2, Na~2~-ATP 4, Na-GTP 0.4, or, alternatively, Cs^+^ methane sulfonate 150, MgCl~2~1.3, EGTA 1, HEPES 10, CaCl 0.1. AMPAR EPSCs in CA1 pyramidal cells were recorded at V~m~ = -70 mV, and NMDAR EPSCs were recorded in at V~m~ = −10 mV in the presence of 10 μM NBQX, unless indicated otherwise.

Where required, slices were pre-incubated in the glial metabolism inhibitor sodium fluoroacetate (FAC)[@R34] for at least 50 minutes, unless indicated otherwise; D-serine was added 10 to 15 minutes prior to LTP induction. Recordings were carried out using a Multiclamp 700A or 700B (Molecular Devices). Signals were filtered at 3-6 kHz, digitized and sampled through an AD converter (National Instruments) at 10 kHz, and stored for off-line analysis using either LabView (National Instruments) routines or pClamp9 software (Molecular Devices). Receptor blockers were purchased from Tocris, FAC from Sigma-Aldrich.

Two-photon excitation imaging {#S5}
-----------------------------

We used a Radiance 2100 imaging system (Zeiss-Biorad) optically linked to a femtosecond pulse laser MaiTai (SpectraPhysics-Newport) and integrated with patch-clamp electrophysiology[@R35]. Once in whole-cell mode, Alexa normally equilibrated across the astrocyte tree within 10-15 min. Astrocytes loaded with fluorescence indicators (see above) were imaged as 3-D stacks of 60-100 optical sections in the Alexa emission channel (540LP/700SP filter; λ~x~^2P^ = 800 nm), collected in image frame mode (512 × 512 pixels, 8-bit) at 0.5-1 μm steps.

For illustration purposes, the stacks were z-axis averaged using ImageJ routines (Rasband WS, ImageJ, NIH, Bethesda, Maryland, USA, <http://rsb.info.nih.gov/ij/>, 1997-2008). Transient Ca^2+^ signals evoked in patched astrocytes by HFS ([Supplementary Fig. 2](#SD1){ref-type="supplementary-material"}) were imaged in the OGB-1 (green) channel (515/30 filter) in line scan mode (500 Hz), and corrected for focus fluctuations in the Alexa (red) channel, as detailed elsewhere[@R35]-[@R37] and illustrated in [Supplementary Fig. 2](#SD1){ref-type="supplementary-material"}.

To image Ca^2+^ activity simultaneously in a population of astrocytes ([Supplementary Fig. 7](#SD1){ref-type="supplementary-material"}), slices were incubated with the glia-specific dye sulforhodamine 101 (5 μM, SR101, Invitrogen) and the Ca^2+^-indicator Fluo-4 AM or OGB-1 AM (5 μM, Invitrogen), in the presence of 0.04% Pluronic (Invitrogen), for 40-50 minutes at 37 °C and allowed to rest for at least 20 minutes. The viability of loaded slices was verified by monitoring fEPSPs in response to Schaffer collateral stimulation, as described above. Time lapse imaging was carried out by acquiring 800-20000 pairs of SR101 and Fluo4 / OGB-1 fluorescence image frames at a rate of 2 Hz (256 × 256 pixels) or 7 Hz (64 × 64 pixels). In order to evoke a Ca^2+^ response, HFS (100 pulses at 100 Hz) was delivered halfway through the experiment. In these experiments, time-dependent fluorescent transients were expressed as *F*/*F*~0~ where *F* denotes the averaged, background-corrected Fluo-4 / OGB-1 fluorescence of a SR101 positive (astrocytic) soma.

Visualisation of astrocytic pairs and separating images of individual astrocytes in dual-patch experiments (Fig. 5) was carried out using the following routine: (a) cell 1 was patched, the dye was allowed to equilibrate and the resulting "cell-1 image" (3-D stack) was stored; (b) cell 2 was patched, the dye was equilibrated and the resulting "cell-1 + cell-2 image" was stored; (c) "cell-1 image" was subtracted from "cell-1 + cell-2 image" thus yielding the fluorescent "cell-2 image". Comparing "cell-1 image" and "cell-2 image" could be used to reveal staining (diffusion) overlap between the two cells, which could be visualised using false colour tables applied to the two images. Image analyses were carried out offline using ImageJ.

Statistics {#S6}
----------

Group data are routinely reported as mean ± s.e.m., unless indicated otherwise, and the statistical difference between the population averages was estimated using the *t*-test (for paired or independent samples). Two-tailed tests were routinely used, and sample pairing was used where appropriate, e.g., when monitoring real-time changes in a parameter against its baseline value or when comparing cells in paired recordings.
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![Clamping astrocytic Ca^2+^ blocks LTP at nearby synapses in a D-serine-dependent manner\
**a,** Experimental arrangement: *ip*, intracellular patch-pipette; *ep*, extracellular pipette; green line, Schaffer collaterals.\
**b,** A typical patched astrocyte (Alexa Fluor 594, \~120 μm stack fusion); *ep* and *ip* as in **a**; *bv*, blood vessel; escape of Alexa to neighbouring cells can be seen; inset: DIC at lower magnification.\
**c,** LTP of AMPAR fEPSPs in control conditions, with (n = 23, green) or without (n = 29, grey) astrocyte patched. Arrow, HFS onset; traces, characteristic AMPAR fEPSPs before (black) and after (grey) LTP induction; notations apply in **c-e**.\
**d,** Clamping astrocytic Ca^2+^ (0.2 mM OGB-1, 0.45 mM EGTA, 0.14 mM CaCl~2~) abolishes local LTP (n = 19, orange) whereas 10 μM D-serine rescues it (n = 10, green).\
**e,** LTP in 10 μM D-serine (163 ± 12%, n = 8, green; no astrocyte patched) is no different from that in control ([Fig. 1c](#F1){ref-type="fig"}) suggesting saturation of either the NMDAR co-agonist site or the downstream induction mechanism. 50 μM APV completely blocks LTP (n = 12, orange).\
**f,** Summary for experiments in **c-e**, as indicated. Bars, mean ± s.e.m for fEPSPs measured 25-30 min post-HFS relative to baseline. \*\*\*, p \< 0.005 (one-population *t*-test); ^+++^, p \< 0.002 (two-population *t*-test).](ukmss-28098-f0001){#F1}

![Activation of the NMDAR co-agonist site is astrocyte- and use-dependent\
**a**, NMDAR fEPSP slope ([Fig. 1a arrangement](#F1){ref-type="fig"}) monitored during the transition from cell-attached to whole-cell mode, as indicated. Grey circles, control (n = 6; Methods); orange, Ca^2+^ clamp (n = 7 throughout, n = 13 before D-serine application); green, Ca^2+^ clamp with 10 μM D-serine in bath (n = 7). Segments, averaging epochs; traces, examples (also [Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}).\
**b,** Summary of experiments shown in **a**. Bars, mean ± s.e.m. (applies throughout); numerals, epochs in **a**. \*\*\*, p \< 0.0001 (one-population *t*-test); ^+++^, p \< 0.005 (two-population *t*-tests).\
**c,** The effect of D-serine on NMDAR EPSCs before and after LTP induction. Green circles, the amplitude of AMPAR EPSCs (n = 6; left panel; V~m~ = −70 mV) and, subsequently, NMDAR EPSCs in the same cell post-LTP (right panel; 10 μM NBQX, V~m~ = −10 mV); grey segment, D-serine application. Open circles (n = 5; top axis, right panel), NMDAR EPSC amplitudes in no-LTP conditions. Traces: upper-left, characteristic AMPAR EPSCs in control (black) and post-LTP (grey); lower-right, NMDAR EPSCs before (black) and after (grey) application of D-serine, in control and post-LTP, as indicated.\
**d**, 10 pulses at 50 Hz transiently potentiates synaptic NMDAR responses in a glycine- and glia- dependent manner. Traces: examples of single-stimulus EPSCs including a prominent NMDAR-mediated component (V~m~ = +40 mV; no AMPAR blockade was used to ensure pharmacological continuity with LTP induction protocols) in baseline conditions (left; grey, individual traces; black, average), 20 seconds (middle), and 2 min after the stimulus train (right), in control (upper row) and in 0.1 mM glycine (lower row). Bar graph: average ratio (post-train EPSC potentiation in glycine) / (post-train EPSC potentiation in control) for test experiments illustrated by traces (green; average change of the NMDAR-mediated response expressed as the area under the EPSC curve over the 100-300 ms post-peak interval: −23 ± 8%, p = 0.032, n = 6), and also for control experiments (orange) including AMPAR EPSCs (amplitude change 5 ± 9%; p = 0.41, n = 4) and NMDAR EPSCs in FAC (15 ± 14%; p = 0.32, n = 6), as indicated (examples in [Supplementary Fig. 6](#SD1){ref-type="supplementary-material"}); circles, individual experiments.](ukmss-28098-f0002){#F2}

![LTP expression depends on the occupancy of the NMDAR co-agonist sites controlled by D-serine synthesis in a nearby astrocyte\
**a**, LTP of AMPAR fEPSPs in control conditions (n = 10; green circles) is abolished by either 50 μM APV (open circles, n = 12) or 750 nM DCKA (n = 9; orange; dose-response curve in [Supplementary Fig. 8](#SD1){ref-type="supplementary-material"}). Traces, characteristic responses in control (black) and following LTP induction (grey).\
**b**, Incubation with 5 mM FAC for \>50 min blocks LTP (n = 16, orange circles) whereas 10 μM D-serine rescues it (n = 16; green circles). Notation is as in **a**.\
**c**, Summary of experiments depicted in **a-b**. Bars, mean ± s.e.m. (applies throughout); \*, p = 0.0127; \*\*, p = 0.0014; \*\*\*, p \< 0.001 (two-population *t*-test).\
**d,** 400 μM intra-astrocyte HOAsp does not suppress LTP induction (potentiation is 50 ± 15%, n = 6, p = 0.021; arrangement as in [Fig. 1a](#F1){ref-type="fig"}); traces, average fEPSPs before (black) and after (grey) application of HFS, one-cell example; time scale applies to **d-e**.\
**e**, Intra-astrocyte HOAsp blocks induction of LTP (fEPSP change: +12 ± 11%, n = 7, p = 0.32; orange) following depletion of D-serine using HFS in APV; arrows, HFS onset. Omitting HOAsp robustly induces LTP (52 ± 11%, n = 6, p = 0.0052; green). HOAsp was unlikely to affect glutamate metabolism because no rundown of glutamatergic responses was observed.\
**f**, Summary of experiments shown in **d-e.** \* (left), p = 0.021; \*\*, p = 0.0052 (one-population *t*-test); \* (right), p = 0.024 (two-population *t*-test).](ukmss-28098-f0003){#F3}

![Individual astrocytes influence LTP induction mainly at nearby synapses\
**a,** Experimental arrangement; notations as in [Fig. 1**a**](#F1){ref-type="fig"}.\
**b-c,** An experiment seen in DIC (**b**) and in Alexa channel (**c**); *a1* and *a2*, two patched astrocytes (λ~x~^2P^ = 800 nm, \~150 μm z-stack; false colours: sequential staining of *a1* and *a2* followed by subtraction of *a1* image from combined *a1*+*a2* image, Methods); *st*, stimulating electrode.\
**d,** Ca^2+^ clamp in test astrocyte suppresses local LTP, but not LTP near the neighbouring control astrocyte. Graph, a-fEPSP amplitudes (mean ± s.e.m.) recorded from the control (green) and test (orange) astrocyte (n = 9). Traces, respective characteristic a-fEPSPs ([Supplementary Fig. 11](#SD1){ref-type="supplementary-material"}) recorded before (black) and after (grey) LTP induction. Incomplete blockade of early potentiation near the test cell was likely due to delayed equilibration between the two dialysing pipettes.\
**e**, Summary of experiments in **d;** connected circles, recorded astrocyte pairs; black and hollow circles, experiments in which the test cell was, respectively, closer to and further away from the stimulating electrode (which might bias LTP expression); p-values, paired *t*-test (n = 9).\
**f-g,** Experiments similar to those shown in **d-e**, but with the test astrocyte loaded with the LC-TT (n = 8). Other notation is as in **d-e**. Slow equilibration of high molecular weight LC-TT might explain incomplete block of early potentiation near the test cell.\
**h**, Left panel, experimental arrangement (as in [Fig. 1a-b](#F1){ref-type="fig"}): dotted cones, depiction of the extracellular pipette (*ep*). Graph: circles, relative potentiation (± s.e.m.) of AMPAR fEPSPs at different distances from the patched soma in control (n = 34; green), Ca^2+^-clamp (n = 48; open orange) and LC-TT (n = 15, filled orange) experiments. Dashed red line, the average emission intensity profile of Alexa (whole-cell loaded at 40 μM) escaping to neighbouring cells (n = 215 astrocytes imaged in eight 3-D stacks; details in [Supplementary Fig. 13](#SD1){ref-type="supplementary-material"}).](ukmss-28098-f0004){#F4}
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